Nextensa Valuation
| NEXTA Stock | 39.00 0.40 1.02% |
At this time, the firm appears to be overvalued. Nextensa NV secures a last-minute Real Value of USD31.98 per share. The latest price of the firm is USD39.0. Our model forecasts the value of Nextensa NV from analyzing the firm fundamentals such as Return On Equity of 0.0869, current valuation of 1.27 B, and Profit Margin of 0.43 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Nextensa's price fluctuation is very steady at this time. Calculation of the real value of Nextensa NV is based on 3 months time horizon. Increasing Nextensa's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Nextensa is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nextensa Stock. However, Nextensa's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 39.0 | Real 31.98 | Hype 39.0 | Naive 38.75 |
The real value of Nextensa Stock, also known as its intrinsic value, is the underlying worth of Nextensa NV Company, which is reflected in its stock price. It is based on Nextensa's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Nextensa's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Nextensa NV helps investors to forecast how Nextensa stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nextensa more accurately as focusing exclusively on Nextensa's fundamentals will not take into account other important factors: Nextensa Total Value Analysis
Nextensa NV is now forecasted to have takeover price of 1.27 B with market capitalization of 472.01 M, debt of 554.2 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Nextensa fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.27 B | 472.01 M | 554.2 M |
Nextensa Investor Information
About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.58. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nextensa NV recorded earning per share (EPS) of 5.21. The entity last dividend was issued on the 19th of May 2022. Based on the key measurements obtained from Nextensa's financial statements, Nextensa NV is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Nextensa Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nextensa has an asset utilization ratio of 5.0 percent. This suggests that the Company is making USD0.05 for each dollar of assets. An increasing asset utilization means that Nextensa NV is more efficient with each dollar of assets it utilizes for everyday operations.Nextensa Ownership Allocation
The market capitalization of Nextensa NV is USD472.01 Million. The majority of Nextensa outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Nextensa NV to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Nextensa NV. Please pay attention to any change in the institutional holdings of Nextensa as this could imply that something significant has changed or is about to change at the company. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.Nextensa Profitability Analysis
The company reported the revenue of 94.8 M. Net Income was 53.24 M with profit before overhead, payroll, taxes, and interest of 65.63 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Nextensa's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Nextensa and how it compares across the competition.
About Nextensa Valuation
The stock valuation mechanism determines Nextensa's current worth on a weekly basis. Our valuation model uses a comparative analysis of Nextensa. We calculate exposure to Nextensa's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nextensa's related companies.8 Steps to conduct Nextensa's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Nextensa's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Nextensa's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Nextensa's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Nextensa's revenue streams: Identify Nextensa's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Nextensa's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Nextensa's growth potential: Evaluate Nextensa's management, business model, and growth potential.
- Determine Nextensa's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Nextensa's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Nextensa Stock analysis
When running Nextensa's price analysis, check to measure Nextensa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nextensa is operating at the current time. Most of Nextensa's value examination focuses on studying past and present price action to predict the probability of Nextensa's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nextensa's price. Additionally, you may evaluate how the addition of Nextensa to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |